metformin has been researched along with Femoral Fractures in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Femoral Fractures: Fractures of the femur.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeyabalan, J | 1 |
| Viollet, B | 1 |
| Smitham, P | 1 |
| Ellis, SA | 1 |
| Zaman, G | 1 |
| Bardin, C | 1 |
| Goodship, A | 1 |
| Roux, JP | 1 |
| Pierre, M | 1 |
| Chenu, C | 1 |
1 other study available for metformin and Femoral Fractures
| Article | Year |
|---|---|
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.
Topics: AMP-Activated Protein Kinases; Animals; Bone Density; Bone Remodeling; Bony Callus; Enzyme Activatio | 2013 |